Liberty Health Archives - Green Market Report

Debra BorchardtDecember 11, 2018

MPX Bioceutical

MPX Bioceutical Corporation (CSE: MPX; OTC: MPXEF) announced that GreenMart NLV, LLC, a subsidiary of MPX, has been awarded four conditional retail marijuana store licenses in the state of Nevada.

GreenMart is a fully-operational cultivation, production, and kitchen facility that produces MPX-branded wholesale products for both the adult-use and medical markets in Nevada. The new dispensaries will operate under the “Health for Life” brand, which is the company’s flagship retail brand. Nevada recorded more than half a billion dollars in cannabis sales during the first year that adult use was legal, according to the Nevada Department of Taxation, exceeding many expectations.

MedMen Enterprises

MedMen (MMEN.CN) (MMNFF) announced that it has closed its previously announced acquisition of a dispensary license in Emeryville, California from B12, LLC.

MedMen paid a combination of cash at closing and shares of MedMen in an undisclosed amount. The transaction closed within 90 days of signing. With the closing of the acquisition, MedMen will have one of only two adult-use cannabis dispensary licenses issued in the City of Emeryville, just outside San Francisco. MedMen currently operates eight dispensaries in Southern California. The Emeryville dispensary will be located in the commercial heart of the East Bay and is expected to open in 2019.

In the last month, MedMen acquired additional licenses in Arizona. Through the acquisition of PharmaCann, MedMen will own an additional twenty-five licenses across 12 states (permitting operation of an additional 18 retail facilities and 7 cultivation/manufacturing facilities).

Liberty Health Sciences Inc.

Liberty Health (CSE: LHS) (OTCQX: LHSIF) opened its first South Florida dispensary in the heart of Miami. The new dispensary provides customers in Miami-Dade County, the most populous county in Florida, access to premium quality medical marijuana products and educational services.

Located at 6827 Bird Road, Miami, FL., the dispensary is on one of the oldest and busiest state roads in Miami, with traffic exceeding 70,000 vehicles per day. The company said that it is a primary artery that feeds the main suburbs in Miami such as Coral Gables, West Miami, South Miami, Westchester, and Kendall. In addition to the Miami location, Liberty plans to open 3 more dispensaries this month with more to come in 2019, all subject to the receipt of the Florida Department of Health approvals.

“Liberty remains committed to ensuring that its premium quality medical marijuana products and educational services are accessible to the more than 2.7 million people who call South Florida home,” said George Scorsis, CEO of Liberty Health Sciences. “When people come to our dispensaries, they know they will find the highest quality medicinal cannabis. They also trust that they are going to have access to the best brands in any category, including PAX and Mary’s Medicinals products.

Debra BorchardtMay 25, 2018

It’s time for your Daily Hit of cannabis financial news for May 25, 2018.

Stock markets are closed on Monday for the Memorial Holiday weekend.

On The Site

Khiron Life Sciences Corp.

Khiron Life Sciences Corp. (KHRN), is a medical marijuana company with its core operations in Colombia that began trading on the Toronto Ventures Exchange on Thursday. The stock jumped 18% on the first day of trading to close at C$1.18.

The company’s strategy isn’t based on how Colombia can export its product to Canada but instead will focus on developing domestic markets within Columbia. “Today that is not really possible,” said Alvaro Torres, the President, and CEO of Khiron. “It is true that we can grow medical cannabis at a much lower cost and Colombia allows for exports, but that is not our focus. Eventually, though it will happen.”

In Other News

Liberty Health Sciences Inc.

Liberty Health Sciences Inc. (LHSIF) announced the expansion of its partnership with Colorado-based MM Technology Holdings to be the exclusive provider of the award-winning line of Mary’s Medicinals cannabis products in Massachusetts.

“We are very excited to extend our partnership with Mary’s into Massachusetts, providing consumers with access to award-winning cannabis products featuring safe and effective alternative delivery methods,” said George Scorsis, Director, and CEO of Liberty. “Liberty has always focused on providing high-quality, clean and safe pharmaceutical-grade cannabis, and partnerships with innovative brands like Mary’s ensures we’re also providing consumers with exceptional variety and choices from the best across the industry.”

Aurora Cannabis Inc.

Aurora Cannabis Inc. (ACBFF) has appointed retained KCSA Strategic Communications, a leading New York-based communications firm, to support the company’s strategic communications and investor relations efforts in the United States.

“With American investor interest in Aurora growing rapidly, and a number of significant corporate developments on the way, this is the right moment for us to amplify our outreach to multiple U.S. audiences,” said Cam Battley, Chief Corporate Officer. “Given Aurora’s status as a global leader in the cannabis sector, we are adding skilled resources, both internally and externally, to help us share the Company’s story of agility, innovation and execution with institutional and retail investors in the U.S. and around the world.”

Medical Cannabis Payment Solutions

Medical Cannabis Payment Solutions (REFG), a Nevada corporation specializing in state-of-the-art financial services structured to serve the medical cannabis and banking industries, announced it has acquired two marijuana strains, GrapeApe and Birthday Cake, from the strains’ creator. GrapeApe is an indica strain that has tested at approximately 33 percent THC by volume. Birthday Cake, a sativa strain, is approximately 15 percent THC and 15 percent CBD by volume.

The company also said it will seek to acquire additional licenses for marijuana cultivation and will work to develop licensing agreements with other state-sanctioned cannabis establishments. The cultivation licenses will be sought via the company’s newly acquired subsidiary, SpeedyGrow.

William SumnerFebruary 5, 2018

Aphria Inc. (APH), a medical cannabis company based in Leamington, Ontario, has begun to divest from some of its passive assets in the United States and is making a killing in the process. Today the company announced that it had entered into an to sell all of its shares in Liberty Health Sciences Inc. (LHS) that are not subject to Canadian Securities Exchange (CSE) escrow requirements.

The transaction comes in the wake of speculation as to how the CSE and the Toronto Stock Exchange (TSX) will treat Canadian cannabis companies with operations in the United States, where cannabis is still federally illegal. On Friday Aphria began to divest from its U.S. interests when it announced the sale of its interests in Copperstate Farms in Arizona to Liberty Health.

Under this latest transaction, Aphria will sell 26,716,025 shares in Liberty, at a discounted price of $1.25 per share, for a gain of approximately $27 million. The cost of the divested shares was $0.234 per share.

In exchange for selling the shares, Aphria will receive short-term notes for $33,395,031. The short-term notes are non-interest bearing and due on February 26, 2018. The statement said that “As security for the notes, each of the buyers provided the company a guarantee.” Approximately 80% of the shares are being purchased by Michael Serruya, Simon Serruya, and Jack Serruya; either individually or through an affiliate. The remaining 20% of shares are being sold to by an affiliate of Delavaco Capital.

Included in the transaction is a call/put option for the remainder of Aphria’s shares in Liberty, which are still subject to CSE escrow requirements. Each purchaser will sign a promissory note which guarantees the purchaser’s obligations under both promissory note as well as upon the exercise of the call/put option.

Upon close of the transaction, Aphria will still retain approximately 28.1% of issued and outstanding shares of Liberty. John Cervini, of Aphria, will remain on Liberty’s board of directors as well as Aphria CEO Vic Neufeld, who will remain as on Chair of the Board.

“Liberty remains very well positioned to capitalize on opportunities in the U.S. medical cannabis industry and Aphria has received excellent value for its investment in this growing company,” said Neufeld. “Liberty’s success is a testament to its hard work and strong management team and we look forward to watching their continued success as they forge ahead with their growth plans in the U.S.”

Liberty will continue to retain the rights to use of Aphria’s trademarks and preserve its interest in the Aphria Know-How System. In the event that the TSX amends their regulations to allow companies to hold U.S. based cannabis investments, the transaction includes an opt-out option for Aphria; upon which the company agrees to pay $2.5 million to the buyers on a pro-rated basis.

StaffOctober 24, 2017

Liberty Health Sciences Inc. (LHSIF) announced a partnership with Colorado-based MM Technology Holdings, LLC otherwise known as Mary’s Medicinals cannabis products to bring the products to the Florida market. Under the three-year agreement, Liberty will produce and distribute a suite of effective and reliable products from Mary’s under license in the State of Florida to further optimize patient care.

“Our goal is to provide the best available medical cannabis products to our patients and Mary’s has a proven track record of success in the space,” said George Scorsis, CEO, and Director of Liberty. “We’re very pleased to be partnering with the company to bring their award-winning products to the Florida market and offer alternative methods of using medical cannabis. This partnership further ensures our patients have access to the most effective medicine on the market today.”

Mary’s is one of the oldest medical marijuana products on the market with its effective and natural pain-relief line of solutions that are clinically tested and use accurate delivery methods. The company rates 4.0 out of 5 stars on Leafly. Mary’s is dedicated to developing innovative products, which have garnered numerous accolades including 2014 Invention of the Year in the Cannabis Business Awards, Most Innovative Product at the CannAwards and Best New Product at the High Times Cannabis Cup.

“Mary’s and Liberty share a patient-first mentality, which makes our partnership a natural fit,” said Lynn Honderd, CEO of Mary’s. “We’re pleased to join forces with the team at Liberty to help bring new forms of relief to Florida patients.”

According to the statement, “Liberty is committed to delivering high-quality, clean and safe pharmaceutical grade cannabis and this agreement with Mary’s elevates the number of cutting-edge products available to its patients. Best known as the developer and exclusive distributor of the award-winning Transdermal Cannabis Patch, Mary innovates at the intersection of technology and horticulture and is transforming how people view and utilize cannabis, developing products that maximize the benefits of cannabinoids, terpenes, and other plant nutrients.”

Battle Begins in Florida over ‘Best Attempt Yet’ for Recreational Marijuana

Daily Hit: May 31, 2023

In other news

Cronos Exiting U.S. Hemp CBD Market

Skymint to Hit Auction Block with Lender as Stalking Horse Bidder

MedMen Trims Losses, But Still a Going Concern

Liberty Health Archives - Green Market Report

Dispensary Updates From MPX, MedMen, Liberty Health

The Daily Hit: May 25, 2018

On The Site

In Other News

Aphria Makes $27 Million In Liberty Health Investment

Liberty Health Sciences Signs Exclusive Deal With Mary’s Medicinals

Battle Begins in Florida over 'Best Attempt Yet' for Recreational Marijuana

Daily Hit: May 31, 2023

Cronos Exiting U.S. Hemp CBD Market

On The Site

In Other News

Get the latest cannabis news delivered right to your inbox

Get the latest cannabis news delivered right to your inbox